Trials / Terminated
TerminatedNCT04958304
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
Moderna mRNA-1273 Observational Pregnancy Outcome Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- ModernaTX, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main goal of this study is to evaluate the outcomes of pregnancy in females exposed to the Moderna COVID-19 vaccine (mRNA-1273) during pregnancy.
Detailed description
The Moderna COVID-19 Vaccine Pregnancy Registry will collect and analyze information on the potential impact of exposure to the Moderna COVID-19 vaccine on pregnancy and birth outcomes.
Conditions
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2023-09-22
- Completion
- 2023-09-22
- First posted
- 2021-07-12
- Last updated
- 2023-11-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04958304. Inclusion in this directory is not an endorsement.